nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—RPS6KB1—dilated cardiomyopathy	0.494	1	CbGaD
Sunitinib—ABCC2—Spironolactone—dilated cardiomyopathy	0.0367	0.42	CbGbCtD
Sunitinib—ABCC2—Furosemide—dilated cardiomyopathy	0.0251	0.287	CbGbCtD
Sunitinib—ABCB1—Lisinopril—dilated cardiomyopathy	0.0136	0.156	CbGbCtD
Sunitinib—ABCB1—Spironolactone—dilated cardiomyopathy	0.012	0.137	CbGbCtD
Sunitinib—Unspecified visual loss—Lisinopril—dilated cardiomyopathy	0.00246	0.0343	CcSEcCtD
Sunitinib—Procainamide—SCN5A—dilated cardiomyopathy	0.00208	0.635	CrCbGaD
Sunitinib—Infarction—Lisinopril—dilated cardiomyopathy	0.00194	0.027	CcSEcCtD
Sunitinib—Skin infection—Lisinopril—dilated cardiomyopathy	0.00178	0.0248	CcSEcCtD
Sunitinib—TLK2—Progesterone—Spironolactone—dilated cardiomyopathy	0.00173	0.531	CbGdCrCtD
Sunitinib—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.00172	0.0239	CcSEcCtD
Sunitinib—MYLK2—heart—dilated cardiomyopathy	0.00153	0.0112	CbGeAlD
Sunitinib—MYLK3—cardiac ventricle—dilated cardiomyopathy	0.00146	0.0107	CbGeAlD
Sunitinib—Flank pain—Lisinopril—dilated cardiomyopathy	0.00134	0.0186	CcSEcCtD
Sunitinib—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0013	0.018	CcSEcCtD
Sunitinib—PRKAA2—cardiac ventricle—dilated cardiomyopathy	0.00123	0.00897	CbGeAlD
Sunitinib—Procainamide—SLC22A5—dilated cardiomyopathy	0.0012	0.365	CrCbGaD
Sunitinib—MAP4K4—Testosterone Propionate—Spironolactone—dilated cardiomyopathy	0.00119	0.366	CbGdCrCtD
Sunitinib—PRKAA2—myocardium—dilated cardiomyopathy	0.00115	0.00844	CbGeAlD
Sunitinib—STK17A—cardiac ventricle—dilated cardiomyopathy	0.00109	0.00796	CbGeAlD
Sunitinib—Transient ischaemic attack—Lisinopril—dilated cardiomyopathy	0.00107	0.0148	CcSEcCtD
Sunitinib—GRK4—heart—dilated cardiomyopathy	0.00106	0.00777	CbGeAlD
Sunitinib—LATS2—cardiac ventricle—dilated cardiomyopathy	0.00106	0.00773	CbGeAlD
Sunitinib—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00104	0.0144	CcSEcCtD
Sunitinib—Thrombosis—Furosemide—dilated cardiomyopathy	0.00101	0.0141	CcSEcCtD
Sunitinib—Blister—Furosemide—dilated cardiomyopathy	0.000995	0.0138	CcSEcCtD
Sunitinib—LATS2—myocardium—dilated cardiomyopathy	0.000995	0.00727	CbGeAlD
Sunitinib—TLK2—heart—dilated cardiomyopathy	0.000988	0.00723	CbGeAlD
Sunitinib—RPS6KA5—myocardium—dilated cardiomyopathy	0.000981	0.00718	CbGeAlD
Sunitinib—Blindness—Lisinopril—dilated cardiomyopathy	0.000972	0.0135	CcSEcCtD
Sunitinib—MYLK3—heart—dilated cardiomyopathy	0.000957	0.007	CbGeAlD
Sunitinib—BRD4—cardiac ventricle—dilated cardiomyopathy	0.000939	0.00687	CbGeAlD
Sunitinib—TNIK—cardiac ventricle—dilated cardiomyopathy	0.000912	0.00667	CbGeAlD
Sunitinib—ICK—cardiac ventricle—dilated cardiomyopathy	0.000895	0.00655	CbGeAlD
Sunitinib—BRD4—myocardium—dilated cardiomyopathy	0.000884	0.00646	CbGeAlD
Sunitinib—RIOK1—myocardium—dilated cardiomyopathy	0.000875	0.0064	CbGeAlD
Sunitinib—NUAK1—cardiac ventricle—dilated cardiomyopathy	0.000865	0.00632	CbGeAlD
Sunitinib—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000862	0.012	CcSEcCtD
Sunitinib—TNIK—myocardium—dilated cardiomyopathy	0.000858	0.00627	CbGeAlD
Sunitinib—SNRK—cardiac ventricle—dilated cardiomyopathy	0.000857	0.00627	CbGeAlD
Sunitinib—OXSR1—cardiac ventricle—dilated cardiomyopathy	0.000857	0.00627	CbGeAlD
Sunitinib—INSR—cardiac ventricle—dilated cardiomyopathy	0.000857	0.00627	CbGeAlD
Sunitinib—SGK3—myocardium—dilated cardiomyopathy	0.00085	0.00621	CbGeAlD
Sunitinib—RPS6KA2—cardiac ventricle—dilated cardiomyopathy	0.000844	0.00617	CbGeAlD
Sunitinib—STK38—cardiac ventricle—dilated cardiomyopathy	0.000844	0.00617	CbGeAlD
Sunitinib—CSNK1G2—cardiac ventricle—dilated cardiomyopathy	0.000831	0.00608	CbGeAlD
Sunitinib—PKN1—cardiac ventricle—dilated cardiomyopathy	0.000831	0.00608	CbGeAlD
Sunitinib—PRPF4—cardiac ventricle—dilated cardiomyopathy	0.000819	0.00599	CbGeAlD
Sunitinib—MYLK3—cardiac atrium—dilated cardiomyopathy	0.000819	0.00599	CbGeAlD
Sunitinib—NUAK1—myocardium—dilated cardiomyopathy	0.000813	0.00595	CbGeAlD
Sunitinib—PRPF4B—cardiac ventricle—dilated cardiomyopathy	0.000807	0.0059	CbGeAlD
Sunitinib—INSR—myocardium—dilated cardiomyopathy	0.000807	0.0059	CbGeAlD
Sunitinib—OXSR1—myocardium—dilated cardiomyopathy	0.000807	0.0059	CbGeAlD
Sunitinib—SNRK—myocardium—dilated cardiomyopathy	0.000807	0.0059	CbGeAlD
Sunitinib—PIP4K2B—heart—dilated cardiomyopathy	0.000806	0.00589	CbGeAlD
Sunitinib—ERN1—heart—dilated cardiomyopathy	0.000806	0.00589	CbGeAlD
Sunitinib—PRKAA2—heart—dilated cardiomyopathy	0.000806	0.00589	CbGeAlD
Sunitinib—STK39—cardiac ventricle—dilated cardiomyopathy	0.000796	0.00582	CbGeAlD
Sunitinib—STK38—myocardium—dilated cardiomyopathy	0.000794	0.0058	CbGeAlD
Sunitinib—RPS6KA2—myocardium—dilated cardiomyopathy	0.000794	0.0058	CbGeAlD
Sunitinib—CSNK2A1—cardiac ventricle—dilated cardiomyopathy	0.000786	0.00574	CbGeAlD
Sunitinib—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.000783	0.0109	CcSEcCtD
Sunitinib—STK17B—heart—dilated cardiomyopathy	0.000775	0.00567	CbGeAlD
Sunitinib—MYLK—cardiac ventricle—dilated cardiomyopathy	0.000775	0.00567	CbGeAlD
Sunitinib—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.000773	0.0108	CcSEcCtD
Sunitinib—PRPF4—myocardium—dilated cardiomyopathy	0.00077	0.00563	CbGeAlD
Sunitinib—PRPF4B—myocardium—dilated cardiomyopathy	0.000759	0.00555	CbGeAlD
Sunitinib—STK39—myocardium—dilated cardiomyopathy	0.000749	0.00548	CbGeAlD
Sunitinib—CSNK2A1—myocardium—dilated cardiomyopathy	0.000739	0.0054	CbGeAlD
Sunitinib—DAPK2—cardiac ventricle—dilated cardiomyopathy	0.000735	0.00538	CbGeAlD
Sunitinib—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000731	0.0102	CcSEcCtD
Sunitinib—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00073	0.0102	CcSEcCtD
Sunitinib—MYLK—myocardium—dilated cardiomyopathy	0.000729	0.00533	CbGeAlD
Sunitinib—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.000727	0.0101	CcSEcCtD
Sunitinib—Renal failure—Spironolactone—dilated cardiomyopathy	0.000725	0.0101	CcSEcCtD
Sunitinib—HIPK3—cardiac ventricle—dilated cardiomyopathy	0.000719	0.00526	CbGeAlD
Sunitinib—STK17A—heart—dilated cardiomyopathy	0.000715	0.00522	CbGeAlD
Sunitinib—RIOK2—cardiac ventricle—dilated cardiomyopathy	0.000712	0.00521	CbGeAlD
Sunitinib—CDK14—heart—dilated cardiomyopathy	0.000704	0.00515	CbGeAlD
Sunitinib—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.000703	0.00977	CcSEcCtD
Sunitinib—CDK16—heart—dilated cardiomyopathy	0.000694	0.00508	CbGeAlD
Sunitinib—LATS2—heart—dilated cardiomyopathy	0.000694	0.00508	CbGeAlD
Sunitinib—DAPK2—myocardium—dilated cardiomyopathy	0.000691	0.00506	CbGeAlD
Sunitinib—DAPK3—cardiac ventricle—dilated cardiomyopathy	0.000691	0.00505	CbGeAlD
Sunitinib—PRKAA2—cardiac atrium—dilated cardiomyopathy	0.000689	0.00504	CbGeAlD
Sunitinib—STK33—heart—dilated cardiomyopathy	0.000685	0.00501	CbGeAlD
Sunitinib—RPS6KA5—heart—dilated cardiomyopathy	0.000685	0.00501	CbGeAlD
Sunitinib—HIPK3—myocardium—dilated cardiomyopathy	0.000677	0.00495	CbGeAlD
Sunitinib—RIOK2—myocardium—dilated cardiomyopathy	0.00067	0.0049	CbGeAlD
Sunitinib—CLK4—heart—dilated cardiomyopathy	0.000659	0.00482	CbGeAlD
Sunitinib—DAPK3—myocardium—dilated cardiomyopathy	0.00065	0.00475	CbGeAlD
Sunitinib—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.000649	0.00903	CcSEcCtD
Sunitinib—PHKG1—heart—dilated cardiomyopathy	0.000637	0.00466	CbGeAlD
Sunitinib—DAPK1—heart—dilated cardiomyopathy	0.000637	0.00466	CbGeAlD
Sunitinib—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000626	0.0087	CcSEcCtD
Sunitinib—MAP4K4—cardiac ventricle—dilated cardiomyopathy	0.00062	0.00454	CbGeAlD
Sunitinib—STK11—heart—dilated cardiomyopathy	0.000617	0.00451	CbGeAlD
Sunitinib—BRD4—heart—dilated cardiomyopathy	0.000617	0.00451	CbGeAlD
Sunitinib—Proteinuria—Lisinopril—dilated cardiomyopathy	0.000612	0.00852	CcSEcCtD
Sunitinib—RPS6KA1—heart—dilated cardiomyopathy	0.000611	0.00446	CbGeAlD
Sunitinib—RIOK1—heart—dilated cardiomyopathy	0.000611	0.00446	CbGeAlD
Sunitinib—DYRK1A—myocardium—dilated cardiomyopathy	0.000609	0.00445	CbGeAlD
Sunitinib—Protein urine present—Lisinopril—dilated cardiomyopathy	0.000604	0.0084	CcSEcCtD
Sunitinib—RPS6KA3—cardiac ventricle—dilated cardiomyopathy	0.000603	0.00441	CbGeAlD
Sunitinib—CDK14—cardiac atrium—dilated cardiomyopathy	0.000602	0.0044	CbGeAlD
Sunitinib—TNIK—heart—dilated cardiomyopathy	0.000599	0.00438	CbGeAlD
Sunitinib—MARK2—heart—dilated cardiomyopathy	0.000599	0.00438	CbGeAlD
Sunitinib—Viral infection—Lisinopril—dilated cardiomyopathy	0.000596	0.00829	CcSEcCtD
Sunitinib—LATS2—cardiac atrium—dilated cardiomyopathy	0.000594	0.00434	CbGeAlD
Sunitinib—SGK3—heart—dilated cardiomyopathy	0.000593	0.00434	CbGeAlD
Sunitinib—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.000592	0.00823	CcSEcCtD
Sunitinib—CSNK1A1—cardiac ventricle—dilated cardiomyopathy	0.000591	0.00432	CbGeAlD
Sunitinib—ICK—heart—dilated cardiomyopathy	0.000588	0.0043	CbGeAlD
Sunitinib—CLK1—cardiac ventricle—dilated cardiomyopathy	0.000588	0.0043	CbGeAlD
Sunitinib—RPS6KA5—cardiac atrium—dilated cardiomyopathy	0.000586	0.00428	CbGeAlD
Sunitinib—Alopecia—Spironolactone—dilated cardiomyopathy	0.000585	0.00814	CcSEcCtD
Sunitinib—MAP4K4—myocardium—dilated cardiomyopathy	0.000584	0.00427	CbGeAlD
Sunitinib—NUAK1—heart—dilated cardiomyopathy	0.000568	0.00415	CbGeAlD
Sunitinib—RPS6KA3—myocardium—dilated cardiomyopathy	0.000567	0.00415	CbGeAlD
Sunitinib—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.000565	0.00786	CcSEcCtD
Sunitinib—INSR—heart—dilated cardiomyopathy	0.000563	0.00412	CbGeAlD
Sunitinib—SNRK—heart—dilated cardiomyopathy	0.000563	0.00412	CbGeAlD
Sunitinib—OXSR1—heart—dilated cardiomyopathy	0.000563	0.00412	CbGeAlD
Sunitinib—CSNK1A1—myocardium—dilated cardiomyopathy	0.000556	0.00407	CbGeAlD
Sunitinib—RPS6KA2—heart—dilated cardiomyopathy	0.000554	0.00405	CbGeAlD
Sunitinib—STK38—heart—dilated cardiomyopathy	0.000554	0.00405	CbGeAlD
Sunitinib—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000554	0.00771	CcSEcCtD
Sunitinib—CLK1—myocardium—dilated cardiomyopathy	0.000553	0.00404	CbGeAlD
Sunitinib—AURKC—heart—dilated cardiomyopathy	0.00055	0.00402	CbGeAlD
Sunitinib—CSNK1E—cardiac ventricle—dilated cardiomyopathy	0.000548	0.00401	CbGeAlD
Sunitinib—PKN1—heart—dilated cardiomyopathy	0.000546	0.00399	CbGeAlD
Sunitinib—CSNK1G2—heart—dilated cardiomyopathy	0.000546	0.00399	CbGeAlD
Sunitinib—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000545	0.00758	CcSEcCtD
Sunitinib—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.000545	0.00757	CcSEcCtD
Sunitinib—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000538	0.00748	CcSEcCtD
Sunitinib—PRPF4—heart—dilated cardiomyopathy	0.000538	0.00393	CbGeAlD
Sunitinib—PRPF4B—heart—dilated cardiomyopathy	0.00053	0.00387	CbGeAlD
Sunitinib—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000529	0.00735	CcSEcCtD
Sunitinib—ULK3—cardiac ventricle—dilated cardiomyopathy	0.000528	0.00386	CbGeAlD
Sunitinib—MAP2K2—cardiac ventricle—dilated cardiomyopathy	0.000528	0.00386	CbGeAlD
Sunitinib—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000523	0.00727	CcSEcCtD
Sunitinib—STK39—heart—dilated cardiomyopathy	0.000523	0.00382	CbGeAlD
Sunitinib—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.000523	0.00727	CcSEcCtD
Sunitinib—RIOK1—cardiac atrium—dilated cardiomyopathy	0.000522	0.00382	CbGeAlD
Sunitinib—MAP3K7—cardiac ventricle—dilated cardiomyopathy	0.000519	0.00379	CbGeAlD
Sunitinib—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000516	0.00717	CcSEcCtD
Sunitinib—CSNK2A1—heart—dilated cardiomyopathy	0.000516	0.00377	CbGeAlD
Sunitinib—FGFR1—myocardium—dilated cardiomyopathy	0.000516	0.00377	CbGeAlD
Sunitinib—TBK1—cardiac ventricle—dilated cardiomyopathy	0.000513	0.00375	CbGeAlD
Sunitinib—TYK2—cardiac ventricle—dilated cardiomyopathy	0.00051	0.00373	CbGeAlD
Sunitinib—MYLK—heart—dilated cardiomyopathy	0.000509	0.00372	CbGeAlD
Sunitinib—IRAK1—cardiac ventricle—dilated cardiomyopathy	0.000503	0.00368	CbGeAlD
Sunitinib—ICK—cardiac atrium—dilated cardiomyopathy	0.000503	0.00368	CbGeAlD
Sunitinib—STK4—heart—dilated cardiomyopathy	0.0005	0.00365	CbGeAlD
Sunitinib—MAP2K2—myocardium—dilated cardiomyopathy	0.000496	0.00363	CbGeAlD
Sunitinib—ULK3—myocardium—dilated cardiomyopathy	0.000496	0.00363	CbGeAlD
Sunitinib—RPS6KB1—cardiac ventricle—dilated cardiomyopathy	0.000493	0.00361	CbGeAlD
Sunitinib—PHKG2—heart—dilated cardiomyopathy	0.000491	0.00359	CbGeAlD
Sunitinib—AXL—cardiac ventricle—dilated cardiomyopathy	0.000489	0.00357	CbGeAlD
Sunitinib—STK24—heart—dilated cardiomyopathy	0.000488	0.00357	CbGeAlD
Sunitinib—MAP3K7—myocardium—dilated cardiomyopathy	0.000488	0.00357	CbGeAlD
Sunitinib—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000488	0.00678	CcSEcCtD
Sunitinib—NUAK1—cardiac atrium—dilated cardiomyopathy	0.000485	0.00355	CbGeAlD
Sunitinib—Dehydration—Furosemide—dilated cardiomyopathy	0.000484	0.00673	CcSEcCtD
Sunitinib—DAPK2—heart—dilated cardiomyopathy	0.000483	0.00353	CbGeAlD
Sunitinib—TBK1—myocardium—dilated cardiomyopathy	0.000483	0.00353	CbGeAlD
Sunitinib—INSR—cardiac atrium—dilated cardiomyopathy	0.000481	0.00352	CbGeAlD
Sunitinib—OXSR1—cardiac atrium—dilated cardiomyopathy	0.000481	0.00352	CbGeAlD
Sunitinib—SNRK—cardiac atrium—dilated cardiomyopathy	0.000481	0.00352	CbGeAlD
Sunitinib—TYK2—myocardium—dilated cardiomyopathy	0.000479	0.0035	CbGeAlD
Sunitinib—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000479	0.00666	CcSEcCtD
Sunitinib—STK16—heart—dilated cardiomyopathy	0.000475	0.00347	CbGeAlD
Sunitinib—STK38—cardiac atrium—dilated cardiomyopathy	0.000474	0.00346	CbGeAlD
Sunitinib—RPS6KA2—cardiac atrium—dilated cardiomyopathy	0.000474	0.00346	CbGeAlD
Sunitinib—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000474	0.00659	CcSEcCtD
Sunitinib—IRAK1—myocardium—dilated cardiomyopathy	0.000473	0.00346	CbGeAlD
Sunitinib—HIPK2—heart—dilated cardiomyopathy	0.000472	0.00345	CbGeAlD
Sunitinib—HIPK3—heart—dilated cardiomyopathy	0.000472	0.00345	CbGeAlD
Sunitinib—SLK—cardiac ventricle—dilated cardiomyopathy	0.00047	0.00344	CbGeAlD
Sunitinib—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000469	0.00652	CcSEcCtD
Sunitinib—RIOK2—heart—dilated cardiomyopathy	0.000467	0.00342	CbGeAlD
Sunitinib—TNK1—heart—dilated cardiomyopathy	0.000467	0.00342	CbGeAlD
Sunitinib—PKN1—cardiac atrium—dilated cardiomyopathy	0.000467	0.00341	CbGeAlD
Sunitinib—CSNK1G2—cardiac atrium—dilated cardiomyopathy	0.000467	0.00341	CbGeAlD
Sunitinib—RPS6KB1—myocardium—dilated cardiomyopathy	0.000464	0.00339	CbGeAlD
Sunitinib—JAK2—cardiac ventricle—dilated cardiomyopathy	0.000464	0.00339	CbGeAlD
Sunitinib—MAP4K1—heart—dilated cardiomyopathy	0.000463	0.00338	CbGeAlD
Sunitinib—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00046	0.0064	CcSEcCtD
Sunitinib—PRPF4—cardiac atrium—dilated cardiomyopathy	0.00046	0.00336	CbGeAlD
Sunitinib—AXL—myocardium—dilated cardiomyopathy	0.000459	0.00336	CbGeAlD
Sunitinib—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000459	0.00639	CcSEcCtD
Sunitinib—FYN—cardiac ventricle—dilated cardiomyopathy	0.000457	0.00334	CbGeAlD
Sunitinib—DAPK3—heart—dilated cardiomyopathy	0.000454	0.00332	CbGeAlD
Sunitinib—PRPF4B—cardiac atrium—dilated cardiomyopathy	0.000453	0.00331	CbGeAlD
Sunitinib—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000453	0.0063	CcSEcCtD
Sunitinib—CLK2—heart—dilated cardiomyopathy	0.00045	0.00329	CbGeAlD
Sunitinib—MAP4K2—heart—dilated cardiomyopathy	0.000447	0.00327	CbGeAlD
Sunitinib—STK39—cardiac atrium—dilated cardiomyopathy	0.000447	0.00327	CbGeAlD
Sunitinib—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000447	0.00622	CcSEcCtD
Sunitinib—MAP3K3—cardiac ventricle—dilated cardiomyopathy	0.000447	0.00327	CbGeAlD
Sunitinib—SLK—myocardium—dilated cardiomyopathy	0.000442	0.00323	CbGeAlD
Sunitinib—STK3—heart—dilated cardiomyopathy	0.000441	0.00323	CbGeAlD
Sunitinib—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000441	0.00614	CcSEcCtD
Sunitinib—CSNK2A1—cardiac atrium—dilated cardiomyopathy	0.000441	0.00323	CbGeAlD
Sunitinib—JAK2—myocardium—dilated cardiomyopathy	0.000436	0.00319	CbGeAlD
Sunitinib—ROCK1—heart—dilated cardiomyopathy	0.000436	0.00319	CbGeAlD
Sunitinib—MYLK—cardiac atrium—dilated cardiomyopathy	0.000435	0.00318	CbGeAlD
Sunitinib—Eczema—Lisinopril—dilated cardiomyopathy	0.000435	0.00604	CcSEcCtD
Sunitinib—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000435	0.00604	CcSEcCtD
Sunitinib—FLT1—cardiac ventricle—dilated cardiomyopathy	0.000432	0.00316	CbGeAlD
Sunitinib—FYN—myocardium—dilated cardiomyopathy	0.00043	0.00314	CbGeAlD
Sunitinib—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.000429	0.00596	CcSEcCtD
Sunitinib—DYRK1A—heart—dilated cardiomyopathy	0.000425	0.00311	CbGeAlD
Sunitinib—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000423	0.00588	CcSEcCtD
Sunitinib—MAP3K3—myocardium—dilated cardiomyopathy	0.00042	0.00307	CbGeAlD
Sunitinib—MERTK—heart—dilated cardiomyopathy	0.000415	0.00303	CbGeAlD
Sunitinib—DAPK2—cardiac atrium—dilated cardiomyopathy	0.000413	0.00302	CbGeAlD
Sunitinib—YES1—cardiac ventricle—dilated cardiomyopathy	0.000413	0.00302	CbGeAlD
Sunitinib—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00041	0.00571	CcSEcCtD
Sunitinib—MAP4K4—heart—dilated cardiomyopathy	0.000407	0.00298	CbGeAlD
Sunitinib—TAOK3—cardiac ventricle—dilated cardiomyopathy	0.000407	0.00298	CbGeAlD
Sunitinib—FLT1—myocardium—dilated cardiomyopathy	0.000406	0.00297	CbGeAlD
Sunitinib—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000406	0.00565	CcSEcCtD
Sunitinib—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000406	0.00564	CcSEcCtD
Sunitinib—HIPK3—cardiac atrium—dilated cardiomyopathy	0.000404	0.00295	CbGeAlD
Sunitinib—MAP3K12—heart—dilated cardiomyopathy	0.000402	0.00294	CbGeAlD
Sunitinib—FLT3—heart—dilated cardiomyopathy	0.000402	0.00294	CbGeAlD
Sunitinib—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.0004	0.00557	CcSEcCtD
Sunitinib—RIOK2—cardiac atrium—dilated cardiomyopathy	0.0004	0.00292	CbGeAlD
Sunitinib—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000399	0.00554	CcSEcCtD
Sunitinib—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000398	0.00553	CcSEcCtD
Sunitinib—RPS6KA3—heart—dilated cardiomyopathy	0.000396	0.0029	CbGeAlD
Sunitinib—Renal failure—Furosemide—dilated cardiomyopathy	0.000394	0.00548	CcSEcCtD
Sunitinib—MAP2K1—heart—dilated cardiomyopathy	0.000393	0.00288	CbGeAlD
Sunitinib—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000392	0.00545	CcSEcCtD
Sunitinib—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000391	0.00543	CcSEcCtD
Sunitinib—CSNK1A1—heart—dilated cardiomyopathy	0.000388	0.00284	CbGeAlD
Sunitinib—YES1—myocardium—dilated cardiomyopathy	0.000388	0.00284	CbGeAlD
Sunitinib—DAPK3—cardiac atrium—dilated cardiomyopathy	0.000388	0.00284	CbGeAlD
Sunitinib—CLK1—heart—dilated cardiomyopathy	0.000386	0.00282	CbGeAlD
Sunitinib—CLK2—cardiac atrium—dilated cardiomyopathy	0.000384	0.00281	CbGeAlD
Sunitinib—TAOK3—myocardium—dilated cardiomyopathy	0.000383	0.0028	CbGeAlD
Sunitinib—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000379	0.00528	CcSEcCtD
Sunitinib—CAMK2G—heart—dilated cardiomyopathy	0.000379	0.00277	CbGeAlD
Sunitinib—BMP2K—heart—dilated cardiomyopathy	0.000379	0.00277	CbGeAlD
Sunitinib—Face oedema—Lisinopril—dilated cardiomyopathy	0.000377	0.00524	CcSEcCtD
Sunitinib—LRRK2—heart—dilated cardiomyopathy	0.000375	0.00274	CbGeAlD
Sunitinib—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000372	0.00517	CcSEcCtD
Sunitinib—PRKAA1—heart—dilated cardiomyopathy	0.00037	0.0027	CbGeAlD
Sunitinib—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000366	0.00509	CcSEcCtD
Sunitinib—PTK2B—heart—dilated cardiomyopathy	0.000366	0.00267	CbGeAlD
Sunitinib—KDR—cardiac ventricle—dilated cardiomyopathy	0.000365	0.00267	CbGeAlD
Sunitinib—FLT4—heart—dilated cardiomyopathy	0.000365	0.00267	CbGeAlD
Sunitinib—Dehydration—Lisinopril—dilated cardiomyopathy	0.000363	0.00505	CcSEcCtD
Sunitinib—CSNK1E—heart—dilated cardiomyopathy	0.00036	0.00263	CbGeAlD
Sunitinib—FGFR1—heart—dilated cardiomyopathy	0.00036	0.00263	CbGeAlD
Sunitinib—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000356	0.00495	CcSEcCtD
Sunitinib—IRAK4—heart—dilated cardiomyopathy	0.000354	0.00259	CbGeAlD
Sunitinib—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000353	0.00491	CcSEcCtD
Sunitinib—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000352	0.00489	CcSEcCtD
Sunitinib—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000349	0.00486	CcSEcCtD
Sunitinib—MAP4K4—cardiac atrium—dilated cardiomyopathy	0.000348	0.00255	CbGeAlD
Sunitinib—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000346	0.00482	CcSEcCtD
Sunitinib—MAP2K2—heart—dilated cardiomyopathy	0.000346	0.00253	CbGeAlD
Sunitinib—ULK3—heart—dilated cardiomyopathy	0.000346	0.00253	CbGeAlD
Sunitinib—MAP3K2—heart—dilated cardiomyopathy	0.000344	0.00251	CbGeAlD
Sunitinib—KDR—myocardium—dilated cardiomyopathy	0.000343	0.00251	CbGeAlD
Sunitinib—MAP2K5—myocardium—dilated cardiomyopathy	0.000343	0.00251	CbGeAlD
Sunitinib—MAP3K12—cardiac atrium—dilated cardiomyopathy	0.000343	0.00251	CbGeAlD
Sunitinib—MAP3K7—heart—dilated cardiomyopathy	0.000341	0.00249	CbGeAlD
Sunitinib—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00034	0.00474	CcSEcCtD
Sunitinib—RPS6KA3—cardiac atrium—dilated cardiomyopathy	0.000339	0.00248	CbGeAlD
Sunitinib—TBK1—heart—dilated cardiomyopathy	0.000337	0.00246	CbGeAlD
Sunitinib—Eye disorder—Furosemide—dilated cardiomyopathy	0.000337	0.00468	CcSEcCtD
Sunitinib—TYK2—heart—dilated cardiomyopathy	0.000335	0.00245	CbGeAlD
Sunitinib—CHEK2—Testosterone Propionate—Spironolactone—dilated cardiomyopathy	0.000334	0.103	CbGdCrCtD
Sunitinib—Pruritus—Spironolactone—dilated cardiomyopathy	0.000333	0.00463	CcSEcCtD
Sunitinib—CSNK1A1—cardiac atrium—dilated cardiomyopathy	0.000332	0.00243	CbGeAlD
Sunitinib—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000331	0.0046	CcSEcCtD
Sunitinib—IRAK1—heart—dilated cardiomyopathy	0.00033	0.00241	CbGeAlD
Sunitinib—CLK1—cardiac atrium—dilated cardiomyopathy	0.00033	0.00241	CbGeAlD
Sunitinib—Angiopathy—Furosemide—dilated cardiomyopathy	0.000327	0.00454	CcSEcCtD
Sunitinib—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000325	0.00452	CcSEcCtD
Sunitinib—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000325	0.00452	CcSEcCtD
Sunitinib—RPS6KB1—heart—dilated cardiomyopathy	0.000324	0.00237	CbGeAlD
Sunitinib—FGR—heart—dilated cardiomyopathy	0.000322	0.00235	CbGeAlD
Sunitinib—RET—heart—dilated cardiomyopathy	0.000322	0.00235	CbGeAlD
Sunitinib—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000322	0.00448	CcSEcCtD
Sunitinib—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000322	0.00447	CcSEcCtD
Sunitinib—AXL—heart—dilated cardiomyopathy	0.000321	0.00235	CbGeAlD
Sunitinib—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000321	0.00446	CcSEcCtD
Sunitinib—PDGFRB—cardiac ventricle—dilated cardiomyopathy	0.000316	0.00231	CbGeAlD
Sunitinib—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000316	0.00439	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000314	0.00436	CcSEcCtD
Sunitinib—Malnutrition—Furosemide—dilated cardiomyopathy	0.000313	0.00436	CcSEcCtD
Sunitinib—Erythema—Furosemide—dilated cardiomyopathy	0.000313	0.00436	CcSEcCtD
Sunitinib—Dizziness—Spironolactone—dilated cardiomyopathy	0.000311	0.00433	CcSEcCtD
Sunitinib—Flatulence—Furosemide—dilated cardiomyopathy	0.000309	0.0043	CcSEcCtD
Sunitinib—SLK—heart—dilated cardiomyopathy	0.000309	0.00226	CbGeAlD
Sunitinib—FGFR1—cardiac atrium—dilated cardiomyopathy	0.000308	0.00225	CbGeAlD
Sunitinib—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000307	0.00427	CcSEcCtD
Sunitinib—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000305	0.00425	CcSEcCtD
Sunitinib—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000305	0.00424	CcSEcCtD
Sunitinib—KIT—myocardium—dilated cardiomyopathy	0.000304	0.00223	CbGeAlD
Sunitinib—JAK2—heart—dilated cardiomyopathy	0.000304	0.00223	CbGeAlD
Sunitinib—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000303	0.00421	CcSEcCtD
Sunitinib—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000301	0.00419	CcSEcCtD
Sunitinib—FYN—heart—dilated cardiomyopathy	0.0003	0.0022	CbGeAlD
Sunitinib—Depression—Lisinopril—dilated cardiomyopathy	0.0003	0.00417	CcSEcCtD
Sunitinib—Vomiting—Spironolactone—dilated cardiomyopathy	0.000299	0.00416	CcSEcCtD
Sunitinib—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000298	0.00415	CcSEcCtD
Sunitinib—PDGFRB—myocardium—dilated cardiomyopathy	0.000297	0.00217	CbGeAlD
Sunitinib—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000297	0.00413	CcSEcCtD
Sunitinib—Rash—Spironolactone—dilated cardiomyopathy	0.000297	0.00412	CcSEcCtD
Sunitinib—MAP2K2—cardiac atrium—dilated cardiomyopathy	0.000296	0.00217	CbGeAlD
Sunitinib—ULK3—cardiac atrium—dilated cardiomyopathy	0.000296	0.00217	CbGeAlD
Sunitinib—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000296	0.00412	CcSEcCtD
Sunitinib—Renal failure—Lisinopril—dilated cardiomyopathy	0.000296	0.00412	CcSEcCtD
Sunitinib—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000295	0.0041	CcSEcCtD
Sunitinib—Headache—Spironolactone—dilated cardiomyopathy	0.000295	0.0041	CcSEcCtD
Sunitinib—MAP3K3—heart—dilated cardiomyopathy	0.000293	0.00215	CbGeAlD
Sunitinib—MAP4K5—heart—dilated cardiomyopathy	0.000293	0.00215	CbGeAlD
Sunitinib—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000293	0.00407	CcSEcCtD
Sunitinib—MAP3K7—cardiac atrium—dilated cardiomyopathy	0.000291	0.00213	CbGeAlD
Sunitinib—Anaemia—Furosemide—dilated cardiomyopathy	0.00029	0.00403	CcSEcCtD
Sunitinib—TBK1—cardiac atrium—dilated cardiomyopathy	0.000288	0.00211	CbGeAlD
Sunitinib—TYK2—cardiac atrium—dilated cardiomyopathy	0.000286	0.00209	CbGeAlD
Sunitinib—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000285	0.00396	CcSEcCtD
Sunitinib—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000284	0.00395	CcSEcCtD
Sunitinib—FLT1—heart—dilated cardiomyopathy	0.000284	0.00207	CbGeAlD
Sunitinib—Leukopenia—Furosemide—dilated cardiomyopathy	0.000281	0.0039	CcSEcCtD
Sunitinib—EPHB6—heart—dilated cardiomyopathy	0.00028	0.00205	CbGeAlD
Sunitinib—Nausea—Spironolactone—dilated cardiomyopathy	0.000279	0.00389	CcSEcCtD
Sunitinib—RPS6KB1—cardiac atrium—dilated cardiomyopathy	0.000277	0.00203	CbGeAlD
Sunitinib—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000275	0.00383	CcSEcCtD
Sunitinib—AXL—cardiac atrium—dilated cardiomyopathy	0.000274	0.00201	CbGeAlD
Sunitinib—YES1—heart—dilated cardiomyopathy	0.000271	0.00198	CbGeAlD
Sunitinib—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00027	0.00376	CcSEcCtD
Sunitinib—STK10—heart—dilated cardiomyopathy	0.000268	0.00196	CbGeAlD
Sunitinib—TAOK3—heart—dilated cardiomyopathy	0.000267	0.00196	CbGeAlD
Sunitinib—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000267	0.00371	CcSEcCtD
Sunitinib—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000266	0.0037	CcSEcCtD
Sunitinib—PDGFRA—heart—dilated cardiomyopathy	0.000266	0.00194	CbGeAlD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000265	0.00369	CcSEcCtD
Sunitinib—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000265	0.00368	CcSEcCtD
Sunitinib—SLK—cardiac atrium—dilated cardiomyopathy	0.000264	0.00193	CbGeAlD
Sunitinib—Dry mouth—Furosemide—dilated cardiomyopathy	0.000261	0.00363	CcSEcCtD
Sunitinib—JAK2—cardiac atrium—dilated cardiomyopathy	0.00026	0.0019	CbGeAlD
Sunitinib—FYN—cardiac atrium—dilated cardiomyopathy	0.000257	0.00188	CbGeAlD
Sunitinib—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000255	0.00355	CcSEcCtD
Sunitinib—Shock—Furosemide—dilated cardiomyopathy	0.000252	0.0035	CcSEcCtD
Sunitinib—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000251	0.00349	CcSEcCtD
Sunitinib—MAP3K3—cardiac atrium—dilated cardiomyopathy	0.000251	0.00183	CbGeAlD
Sunitinib—MAP4K5—cardiac atrium—dilated cardiomyopathy	0.000251	0.00183	CbGeAlD
Sunitinib—Flushing—Lisinopril—dilated cardiomyopathy	0.000251	0.00349	CcSEcCtD
Sunitinib—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000251	0.00348	CcSEcCtD
Sunitinib—Skin disorder—Furosemide—dilated cardiomyopathy	0.000249	0.00346	CcSEcCtD
Sunitinib—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000245	0.00341	CcSEcCtD
Sunitinib—Anorexia—Furosemide—dilated cardiomyopathy	0.000244	0.00339	CcSEcCtD
Sunitinib—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000244	0.00339	CcSEcCtD
Sunitinib—FLT1—cardiac atrium—dilated cardiomyopathy	0.000243	0.00177	CbGeAlD
Sunitinib—Chills—Lisinopril—dilated cardiomyopathy	0.000242	0.00337	CcSEcCtD
Sunitinib—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000241	0.00336	CcSEcCtD
Sunitinib—EPHB6—cardiac atrium—dilated cardiomyopathy	0.00024	0.00175	CbGeAlD
Sunitinib—KDR—heart—dilated cardiomyopathy	0.00024	0.00175	CbGeAlD
Sunitinib—MAP2K5—heart—dilated cardiomyopathy	0.00024	0.00175	CbGeAlD
Sunitinib—Alopecia—Lisinopril—dilated cardiomyopathy	0.000239	0.00332	CcSEcCtD
Sunitinib—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000237	0.00329	CcSEcCtD
Sunitinib—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000235	0.00327	CcSEcCtD
Sunitinib—Erythema—Lisinopril—dilated cardiomyopathy	0.000235	0.00327	CcSEcCtD
Sunitinib—CSF1R—heart—dilated cardiomyopathy	0.000234	0.00171	CbGeAlD
Sunitinib—Flatulence—Lisinopril—dilated cardiomyopathy	0.000232	0.00322	CcSEcCtD
Sunitinib—YES1—cardiac atrium—dilated cardiomyopathy	0.000232	0.00169	CbGeAlD
Sunitinib—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00023	0.0032	CcSEcCtD
Sunitinib—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00023	0.0032	CcSEcCtD
Sunitinib—TAOK3—cardiac atrium—dilated cardiomyopathy	0.000229	0.00167	CbGeAlD
Sunitinib—Back pain—Lisinopril—dilated cardiomyopathy	0.000228	0.00316	CcSEcCtD
Sunitinib—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000226	0.00315	CcSEcCtD
Sunitinib—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000222	0.00309	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000221	0.00307	CcSEcCtD
Sunitinib—Fatigue—Furosemide—dilated cardiomyopathy	0.000221	0.00307	CcSEcCtD
Sunitinib—Constipation—Furosemide—dilated cardiomyopathy	0.000219	0.00304	CcSEcCtD
Sunitinib—Pain—Furosemide—dilated cardiomyopathy	0.000219	0.00304	CcSEcCtD
Sunitinib—Anaemia—Lisinopril—dilated cardiomyopathy	0.000217	0.00302	CcSEcCtD
Sunitinib—Angioedema—Lisinopril—dilated cardiomyopathy	0.000215	0.00299	CcSEcCtD
Sunitinib—KIT—heart—dilated cardiomyopathy	0.000212	0.00155	CbGeAlD
Sunitinib—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000211	0.00293	CcSEcCtD
Sunitinib—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000209	0.00291	CcSEcCtD
Sunitinib—PDGFRB—heart—dilated cardiomyopathy	0.000208	0.00152	CbGeAlD
Sunitinib—Cough—Lisinopril—dilated cardiomyopathy	0.000205	0.00285	CcSEcCtD
Sunitinib—KDR—cardiac atrium—dilated cardiomyopathy	0.000205	0.0015	CbGeAlD
Sunitinib—MAP2K5—cardiac atrium—dilated cardiomyopathy	0.000205	0.0015	CbGeAlD
Sunitinib—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000202	0.00281	CcSEcCtD
Sunitinib—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000202	0.00281	CcSEcCtD
Sunitinib—Arthralgia—Lisinopril—dilated cardiomyopathy	0.0002	0.00279	CcSEcCtD
Sunitinib—Myalgia—Lisinopril—dilated cardiomyopathy	0.0002	0.00279	CcSEcCtD
Sunitinib—Chest pain—Lisinopril—dilated cardiomyopathy	0.0002	0.00279	CcSEcCtD
Sunitinib—CSF1R—cardiac atrium—dilated cardiomyopathy	0.0002	0.00146	CbGeAlD
Sunitinib—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.0002	0.00146	CbGeAlD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000199	0.00277	CcSEcCtD
Sunitinib—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000196	0.00272	CcSEcCtD
Sunitinib—Oedema—Lisinopril—dilated cardiomyopathy	0.000192	0.00267	CcSEcCtD
Sunitinib—Infection—Lisinopril—dilated cardiomyopathy	0.000191	0.00265	CcSEcCtD
Sunitinib—Shock—Lisinopril—dilated cardiomyopathy	0.000189	0.00263	CcSEcCtD
Sunitinib—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000189	0.00262	CcSEcCtD
Sunitinib—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000188	0.00261	CcSEcCtD
Sunitinib—KCNH2—myocardium—dilated cardiomyopathy	0.000188	0.00137	CbGeAlD
Sunitinib—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000186	0.00259	CcSEcCtD
Sunitinib—Asthenia—Furosemide—dilated cardiomyopathy	0.000184	0.00255	CcSEcCtD
Sunitinib—Anorexia—Lisinopril—dilated cardiomyopathy	0.000183	0.00255	CcSEcCtD
Sunitinib—Pruritus—Furosemide—dilated cardiomyopathy	0.000181	0.00252	CcSEcCtD
Sunitinib—PDGFRB—cardiac atrium—dilated cardiomyopathy	0.000177	0.0013	CbGeAlD
Sunitinib—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000175	0.00243	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000175	0.00243	CcSEcCtD
Sunitinib—Insomnia—Lisinopril—dilated cardiomyopathy	0.000174	0.00241	CcSEcCtD
Sunitinib—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000172	0.0024	CcSEcCtD
Sunitinib—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000171	0.00238	CcSEcCtD
Sunitinib—Dizziness—Furosemide—dilated cardiomyopathy	0.000169	0.00235	CcSEcCtD
Sunitinib—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000169	0.00235	CcSEcCtD
Sunitinib—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000167	0.00232	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000166	0.00231	CcSEcCtD
Sunitinib—Fatigue—Lisinopril—dilated cardiomyopathy	0.000166	0.0023	CcSEcCtD
Sunitinib—ABCC4—heart—dilated cardiomyopathy	0.000165	0.00121	CbGeAlD
Sunitinib—Pain—Lisinopril—dilated cardiomyopathy	0.000164	0.00228	CcSEcCtD
Sunitinib—Constipation—Lisinopril—dilated cardiomyopathy	0.000164	0.00228	CcSEcCtD
Sunitinib—Vomiting—Furosemide—dilated cardiomyopathy	0.000163	0.00226	CcSEcCtD
Sunitinib—Rash—Furosemide—dilated cardiomyopathy	0.000161	0.00224	CcSEcCtD
Sunitinib—Dermatitis—Furosemide—dilated cardiomyopathy	0.000161	0.00224	CcSEcCtD
Sunitinib—Headache—Furosemide—dilated cardiomyopathy	0.00016	0.00223	CcSEcCtD
Sunitinib—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000157	0.00218	CcSEcCtD
Sunitinib—Nausea—Furosemide—dilated cardiomyopathy	0.000152	0.00211	CcSEcCtD
Sunitinib—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000152	0.00211	CcSEcCtD
Sunitinib—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000152	0.00211	CcSEcCtD
Sunitinib—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000141	0.00197	CcSEcCtD
Sunitinib—Asthenia—Lisinopril—dilated cardiomyopathy	0.000138	0.00192	CcSEcCtD
Sunitinib—Pruritus—Lisinopril—dilated cardiomyopathy	0.000136	0.00189	CcSEcCtD
Sunitinib—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000131	0.00183	CcSEcCtD
Sunitinib—KCNH2—heart—dilated cardiomyopathy	0.000131	0.000959	CbGeAlD
Sunitinib—Dizziness—Lisinopril—dilated cardiomyopathy	0.000127	0.00177	CcSEcCtD
Sunitinib—Vomiting—Lisinopril—dilated cardiomyopathy	0.000122	0.0017	CcSEcCtD
Sunitinib—Rash—Lisinopril—dilated cardiomyopathy	0.000121	0.00168	CcSEcCtD
Sunitinib—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000121	0.00168	CcSEcCtD
Sunitinib—Headache—Lisinopril—dilated cardiomyopathy	0.00012	0.00167	CcSEcCtD
Sunitinib—ABCG2—heart—dilated cardiomyopathy	0.000117	0.000853	CbGeAlD
Sunitinib—Nausea—Lisinopril—dilated cardiomyopathy	0.000114	0.00159	CcSEcCtD
Sunitinib—KCNH2—cardiac atrium—dilated cardiomyopathy	0.000112	0.00082	CbGeAlD
Sunitinib—ABCB1—heart—dilated cardiomyopathy	5.75e-05	0.000421	CbGeAlD
Sunitinib—FGFR2—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.44e-06	1.7e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.43e-06	1.69e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AGT—dilated cardiomyopathy	3.42e-06	1.69e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.41e-06	1.68e-05	CbGpPWpGaD
Sunitinib—YES1—Adaptive Immune System—EGFR—dilated cardiomyopathy	3.41e-06	1.68e-05	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—EGFR—dilated cardiomyopathy	3.41e-06	1.68e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.4e-06	1.67e-05	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—EGFR—dilated cardiomyopathy	3.39e-06	1.67e-05	CbGpPWpGaD
Sunitinib—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.39e-06	1.67e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—RAC1—dilated cardiomyopathy	3.39e-06	1.67e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.38e-06	1.67e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.38e-06	1.67e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.38e-06	1.67e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.37e-06	1.66e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.37e-06	1.66e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.37e-06	1.66e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CD36—dilated cardiomyopathy	3.37e-06	1.66e-05	CbGpPWpGaD
Sunitinib—IRAK1—Innate Immune System—EGFR—dilated cardiomyopathy	3.37e-06	1.66e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—RAC1—dilated cardiomyopathy	3.34e-06	1.64e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—RAC1—dilated cardiomyopathy	3.32e-06	1.63e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AGT—dilated cardiomyopathy	3.32e-06	1.63e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AGT—dilated cardiomyopathy	3.32e-06	1.63e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AGT—dilated cardiomyopathy	3.32e-06	1.63e-05	CbGpPWpGaD
Sunitinib—TBK1—Immune System—EGFR—dilated cardiomyopathy	3.32e-06	1.63e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—RAC1—dilated cardiomyopathy	3.28e-06	1.61e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	3.27e-06	1.61e-05	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—EGFR—dilated cardiomyopathy	3.27e-06	1.61e-05	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—EGFR—dilated cardiomyopathy	3.26e-06	1.61e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.26e-06	1.61e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.25e-06	1.6e-05	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—EGFR—dilated cardiomyopathy	3.25e-06	1.6e-05	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—TNF—dilated cardiomyopathy	3.24e-06	1.6e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AGT—dilated cardiomyopathy	3.24e-06	1.59e-05	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—EGFR—dilated cardiomyopathy	3.23e-06	1.59e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.21e-06	1.58e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.2e-06	1.58e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—RAC1—dilated cardiomyopathy	3.2e-06	1.57e-05	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—EGFR—dilated cardiomyopathy	3.18e-06	1.56e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—RAC1—dilated cardiomyopathy	3.17e-06	1.56e-05	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—EGFR—dilated cardiomyopathy	3.17e-06	1.56e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—EGFR—dilated cardiomyopathy	3.17e-06	1.56e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.15e-06	1.55e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—EGFR—dilated cardiomyopathy	3.14e-06	1.54e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.12e-06	1.53e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—EGFR—dilated cardiomyopathy	3.1e-06	1.53e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—EGFR—dilated cardiomyopathy	3.1e-06	1.53e-05	CbGpPWpGaD
Sunitinib—FGFR2—Adaptive Immune System—EGFR—dilated cardiomyopathy	3.1e-06	1.53e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.09e-06	1.52e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—RAC1—dilated cardiomyopathy	3.08e-06	1.52e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	3.08e-06	1.51e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—RAC1—dilated cardiomyopathy	3.07e-06	1.51e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Adaptive Immune System—EGFR—dilated cardiomyopathy	3.04e-06	1.5e-05	CbGpPWpGaD
Sunitinib—KIT—Adaptive Immune System—EGFR—dilated cardiomyopathy	3.04e-06	1.5e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.04e-06	1.5e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.04e-06	1.5e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—RAF1—dilated cardiomyopathy	3.02e-06	1.48e-05	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—EGFR—dilated cardiomyopathy	3.01e-06	1.48e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—EGFR—dilated cardiomyopathy	3.01e-06	1.48e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—EGFR—dilated cardiomyopathy	3e-06	1.48e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3e-06	1.48e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—TNF—dilated cardiomyopathy	2.99e-06	1.47e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.96e-06	1.46e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.96e-06	1.46e-05	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—EGFR—dilated cardiomyopathy	2.95e-06	1.45e-05	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—EGFR—dilated cardiomyopathy	2.95e-06	1.45e-05	CbGpPWpGaD
Sunitinib—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.95e-06	1.45e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.94e-06	1.45e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—EGFR—dilated cardiomyopathy	2.94e-06	1.45e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.93e-06	1.44e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—RAC1—dilated cardiomyopathy	2.93e-06	1.44e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.91e-06	1.44e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—RAF1—dilated cardiomyopathy	2.91e-06	1.44e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.91e-06	1.43e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.91e-06	1.43e-05	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—EGFR—dilated cardiomyopathy	2.89e-06	1.42e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.88e-06	1.42e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—EGFR—dilated cardiomyopathy	2.88e-06	1.42e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—EGFR—dilated cardiomyopathy	2.87e-06	1.42e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—RAF1—dilated cardiomyopathy	2.86e-06	1.41e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—EGFR—dilated cardiomyopathy	2.85e-06	1.41e-05	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—TNF—dilated cardiomyopathy	2.81e-06	1.38e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AGT—dilated cardiomyopathy	2.81e-06	1.38e-05	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—EGFR—dilated cardiomyopathy	2.81e-06	1.38e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—TNF—dilated cardiomyopathy	2.8e-06	1.38e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.79e-06	1.37e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.79e-06	1.37e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.78e-06	1.37e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.78e-06	1.37e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—RAF1—dilated cardiomyopathy	2.78e-06	1.37e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.78e-06	1.37e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.78e-06	1.37e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—EGFR—dilated cardiomyopathy	2.77e-06	1.36e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.77e-06	1.36e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.76e-06	1.36e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.75e-06	1.36e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.75e-06	1.35e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—RAF1—dilated cardiomyopathy	2.74e-06	1.35e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.73e-06	1.35e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—RAF1—dilated cardiomyopathy	2.71e-06	1.33e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.71e-06	1.33e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—EGFR—dilated cardiomyopathy	2.7e-06	1.33e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—RAF1—dilated cardiomyopathy	2.69e-06	1.33e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—RAF1—dilated cardiomyopathy	2.69e-06	1.33e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.67e-06	1.32e-05	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—TNF—dilated cardiomyopathy	2.67e-06	1.32e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AGT—dilated cardiomyopathy	2.66e-06	1.31e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.64e-06	1.3e-05	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—EGFR—dilated cardiomyopathy	2.63e-06	1.3e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—RAC1—dilated cardiomyopathy	2.63e-06	1.29e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—RAC1—dilated cardiomyopathy	2.63e-06	1.29e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—EGFR—dilated cardiomyopathy	2.62e-06	1.29e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.62e-06	1.29e-05	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—EGFR—dilated cardiomyopathy	2.61e-06	1.28e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.6e-06	1.28e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—EGFR—dilated cardiomyopathy	2.6e-06	1.28e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—EGFR—dilated cardiomyopathy	2.59e-06	1.28e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AGT—dilated cardiomyopathy	2.59e-06	1.27e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.58e-06	1.27e-05	CbGpPWpGaD
Sunitinib—BLK—Immune System—EGFR—dilated cardiomyopathy	2.57e-06	1.27e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—RAF1—dilated cardiomyopathy	2.56e-06	1.26e-05	CbGpPWpGaD
Sunitinib—FGR—Immune System—EGFR—dilated cardiomyopathy	2.56e-06	1.26e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—RAF1—dilated cardiomyopathy	2.56e-06	1.26e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AGT—dilated cardiomyopathy	2.55e-06	1.26e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—RAF1—dilated cardiomyopathy	2.55e-06	1.26e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.54e-06	1.25e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—RAF1—dilated cardiomyopathy	2.53e-06	1.25e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AGT—dilated cardiomyopathy	2.51e-06	1.24e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AGT—dilated cardiomyopathy	2.51e-06	1.24e-05	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—EGFR—dilated cardiomyopathy	2.5e-06	1.23e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.49e-06	1.23e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—RAF1—dilated cardiomyopathy	2.49e-06	1.22e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—RAC1—dilated cardiomyopathy	2.49e-06	1.22e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.48e-06	1.22e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.48e-06	1.22e-05	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—EGFR—dilated cardiomyopathy	2.48e-06	1.22e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.47e-06	1.22e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.41e-06	1.19e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.39e-06	1.18e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.39e-06	1.18e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AGT—dilated cardiomyopathy	2.38e-06	1.17e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.38e-06	1.17e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.38e-06	1.17e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AGT—dilated cardiomyopathy	2.37e-06	1.17e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—RAF1—dilated cardiomyopathy	2.36e-06	1.16e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—RAF1—dilated cardiomyopathy	2.35e-06	1.16e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—RAF1—dilated cardiomyopathy	2.35e-06	1.16e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.33e-06	1.15e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.31e-06	1.14e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.3e-06	1.13e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—RAF1—dilated cardiomyopathy	2.3e-06	1.13e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.3e-06	1.13e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—RAF1—dilated cardiomyopathy	2.3e-06	1.13e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.29e-06	1.13e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.27e-06	1.12e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	2.27e-06	1.12e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	2.25e-06	1.11e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—RAF1—dilated cardiomyopathy	2.25e-06	1.11e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—RAC1—dilated cardiomyopathy	2.24e-06	1.1e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—RAF1—dilated cardiomyopathy	2.21e-06	1.09e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—CD36—dilated cardiomyopathy	2.21e-06	1.09e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—RAF1—dilated cardiomyopathy	2.2e-06	1.08e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AGT—dilated cardiomyopathy	2.19e-06	1.08e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	2.19e-06	1.08e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—RAF1—dilated cardiomyopathy	2.17e-06	1.07e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—RAC1—dilated cardiomyopathy	2.16e-06	1.06e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.15e-06	1.06e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AGT—dilated cardiomyopathy	2.14e-06	1.05e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—RAF1—dilated cardiomyopathy	2.12e-06	1.04e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—RAF1—dilated cardiomyopathy	2.1e-06	1.04e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.08e-06	1.03e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—EGFR—dilated cardiomyopathy	2.07e-06	1.02e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AGT—dilated cardiomyopathy	2.06e-06	1.02e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.05e-06	1.01e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AGT—dilated cardiomyopathy	2.05e-06	1.01e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—RAF1—dilated cardiomyopathy	2.04e-06	1.01e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—RAF1—dilated cardiomyopathy	2.03e-06	1e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—EGFR—dilated cardiomyopathy	2e-06	9.84e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AGT—dilated cardiomyopathy	1.99e-06	9.79e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	1.97e-06	9.71e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—EGFR—dilated cardiomyopathy	1.96e-06	9.66e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AGT—dilated cardiomyopathy	1.96e-06	9.65e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.95e-06	9.6e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—RAF1—dilated cardiomyopathy	1.94e-06	9.56e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—EGFR—dilated cardiomyopathy	1.9e-06	9.37e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—EGFR—dilated cardiomyopathy	1.88e-06	9.26e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.88e-06	9.23e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.86e-06	9.15e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.85e-06	9.1e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—EGFR—dilated cardiomyopathy	1.85e-06	9.09e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—EGFR—dilated cardiomyopathy	1.85e-06	9.09e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.8e-06	8.84e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.77e-06	8.73e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.77e-06	8.7e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—EGFR—dilated cardiomyopathy	1.76e-06	8.65e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—EGFR—dilated cardiomyopathy	1.75e-06	8.63e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—EGFR—dilated cardiomyopathy	1.75e-06	8.61e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—RAF1—dilated cardiomyopathy	1.74e-06	8.57e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—RAF1—dilated cardiomyopathy	1.74e-06	8.57e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—EGFR—dilated cardiomyopathy	1.74e-06	8.55e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—EGFR—dilated cardiomyopathy	1.71e-06	8.39e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.7e-06	8.38e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.65e-06	8.14e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.65e-06	8.14e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—RAF1—dilated cardiomyopathy	1.65e-06	8.11e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.64e-06	8.07e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.63e-06	8.02e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	1.63e-06	8e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—EGFR—dilated cardiomyopathy	1.62e-06	7.97e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—EGFR—dilated cardiomyopathy	1.61e-06	7.95e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—EGFR—dilated cardiomyopathy	1.61e-06	7.95e-06	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.59e-06	7.85e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	1.58e-06	7.79e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.58e-06	7.78e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—EGFR—dilated cardiomyopathy	1.58e-06	7.78e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.58e-06	7.78e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—EGFR—dilated cardiomyopathy	1.57e-06	7.75e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—EGFR—dilated cardiomyopathy	1.54e-06	7.58e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.52e-06	7.49e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—EGFR—dilated cardiomyopathy	1.52e-06	7.47e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—EGFR—dilated cardiomyopathy	1.51e-06	7.43e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—EGFR—dilated cardiomyopathy	1.49e-06	7.34e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—RAF1—dilated cardiomyopathy	1.48e-06	7.31e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—EGFR—dilated cardiomyopathy	1.45e-06	7.16e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—EGFR—dilated cardiomyopathy	1.44e-06	7.1e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—RAF1—dilated cardiomyopathy	1.43e-06	7.05e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	1.43e-06	7.02e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.42e-06	7.01e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—EGFR—dilated cardiomyopathy	1.4e-06	6.9e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—EGFR—dilated cardiomyopathy	1.39e-06	6.86e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.36e-06	6.7e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.34e-06	6.58e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—EGFR—dilated cardiomyopathy	1.33e-06	6.56e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.27e-06	6.24e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.23e-06	6.06e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.23e-06	6.04e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.22e-06	5.99e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.19e-06	5.88e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EGFR—dilated cardiomyopathy	1.19e-06	5.88e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EGFR—dilated cardiomyopathy	1.19e-06	5.88e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.13e-06	5.58e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EGFR—dilated cardiomyopathy	1.13e-06	5.56e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.08e-06	5.29e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.04e-06	5.14e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EGFR—dilated cardiomyopathy	1.02e-06	5.01e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EGFR—dilated cardiomyopathy	9.81e-07	4.83e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EGFR—dilated cardiomyopathy	9.76e-07	4.81e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EGFR—dilated cardiomyopathy	9.33e-07	4.59e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	7.56e-07	3.72e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	7.36e-07	3.62e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	6.63e-07	3.26e-06	CbGpPWpGaD
